Phazix - Pill swallowing made simple
For samples or a product evaluation at your facility.

FAQ

  • Phazix is a swallowing gel designed to help those with difficulty swallowing tablets, capsules, and powders.
    • If the text refers to `tablets and capsules’ it is referring to all medications or supplements in solid form, such as pills, tablets, lozenges and capsules, as well as pre-packaged powders.
    • Phazix is not intended to be used with water soluble tablets, dispersible tablets, liquid medication, liquid supplements.
  • If you have questions about this information or this product, please contact ARKRAY.
  • Use medication as directed.
  1. Place tablet, capsule or powder to be taken on a teaspoon.
  2. Apply a full pump from the 500mL bottle onto the tablet, capsule or powder.
    • Approximately 1 teaspoon, one half tablespoon, or 5mL
  3. Place in your mouth and swallow at once.

Phazix Level 3 has a vanilla flavor. It contains the following ingredients: water, sugar, carrageenan, maltodextrin, potassium sorbate (preservative), calcium chloride, citric acid, natural flavor. It has a moderetely thick consistency.

Phazix Level 4 has a vanilla flavor. It contains the following ingredients: water, dried glucose syrup, sugar, maltodextrin, carrageenan, potassium sorbate (preservative),citric acid, and natural flavor. It has a extremely thick consistency.

  1. The gel is thick and smooth to allow for easy swallowing of medications or supplements and a smooth passing through the esophagus to the stomach.
  2. Phazix moistens the mucous membranes in the mouth and throat and may stimulate saliva due to citric acid, allowing the tablet, capsules or powders to pass smoothly through the esophagus.
  3. Phazix breaks down quickly in the stomach and does not affect the absorption rate of medication. Now your medication is available to be delivered the way the manufacturer intended.
  4. The fresh flavor and aroma of Phazix may mask the unpleasant taste and smell of tablets, capsules and powders.

Phazix breaks down quickly in the stomach, therefore, your medication is now available for absorption the way the manufacturer intended.

  • Phazix can be used by anyone who has difficulty swallowing tablets, capsules and powders but can swallow independently.
  • Phazix does not contain gluten, common allergens or gelatin. For a list of common allergens reviewed, contact ARKRAY for information.

If it has been verified by a Pharmacist that the capsule can be opened, Phazix can be used to aid in swallowing.

If it has been verified by a Pharmacist that the capsule can be crushed, Phazix can be used to aid in swallowing.

  • Approximately 1 teaspoon of Phazix is the recommended dosage. With this volume of Phazix, tablets, capsules and powders may go down smoothly.
  • A larger quantity of Phazix can be used with larger quantities of tablets, capsules and powders.
  • Phazix can also be used in several doses.
  • Chilling Phazix will thicken it and may make swallowing easier.
  • It is recommended that Phazix is used by adults as often as pills are taken. Phazix is made with food-safe ingredients and presents a low health risk if consumed in large quantities in error.

It is not necessary to take water with Phazix, but it may be necessary to take water with your medication after intake with Phazix.

With Phazix you can swallow multiple pills at once.

  • Phazix has not been developed specifically for patients with an impaired swallowing reflex.
  • Phazix is not a solution for patients who choke when eating solid food.
  • Phazix should not be used for swallowing medicines in liquid or effervescent form.
  • Stored between 35°F and 77°F (2°C and 25°C).
  • Use Phazix by the Use-by date printed on the packaging.
  • Once opened (bottle seal broken), Phazix should be used within 60 days.
  • Phazix can be disposed of with ordinary household waste.

Healthcare professionals may consider the use of Phazix to address the concerns in this section, §483.45(f) Medication Errors, of the CMS Manual System, Pub. 100-07 State Operations, published by the DHHS, Centers for Medicare and Medicaid Services, effective November 28, 2017. See this section for further information: F760 The facility must ensure that its— §483.45(f)(2) Residents are free of any significant medication errors.1

1. Department of Health & Human Services (DHHS), Centers for Medicare & Medicaid Services (CMS). (2017). Medication Errors of the CMS Manual System, Pub. 100-07 State Operations Manual.